The speaker will discuss insights from behavioral science and answer important questions about unnecessary antibiotic prescribing and successful behavioral interventions that have nearly eliminated inappropriate prescribing. Attendees will learn how to implement changes that will decrease inappropriate antibiotic prescribing while maintaining clinic efficiency and patient satisfaction.
This lecture will address the appropriate use and potential misuse of antibiotic therapy for the primary care practitioner.
Infectious diseases cause some of the more common problems seen in the ambulatory setting and are the most common reasons for prescribing antibiotics. However, choosing appropriate therapy for these disorders can frequently be difficult due to patient demands, practitioner unfamiliarity with appropriate indications for antibiotics, local microbial resistance patterns, and formulary restrictions. The purpose of this talk is to discuss some of the more common infectious diseases seen in outpatient clinics and identify which ones require antibiotic therapy. The speaker will discuss some of the more commonly available antibiotic agents, how to prescribe them appropriately, and some of the problems associated with their use. Participants will also learn about concepts of antibiotic stewardship.
This case-based lecture will provide the active clinician with strategies, updates, and specific practice recommendations in clinical infectious diseases. Prevention and treatment of Infectious Diseases in the ambulatory setting will be emphasized, with coverage of advances in antimicrobial therapy and immunization. Special attention will be given to the responsible use of antibiotics to reduce the risk of both toxicity and antimicrobial resistance.
Turista, Turkey Trot, Delhi Belly. By whatever name one chooses to call it, traveler’s diarrhea (TD) remains the world’s most common travel-related illness. This talk will review the relative risk of acquiring TD by geographic region and patient age, the clinical manifestations of TD’s usual bacterial (80-90%), viral (5-8%) and protozoal (~10%) culprits, as well as pre-travel counseling, traveler-initiated symptomatic treatment, and post-travel management. Through a series of case vignettes, the talk will also highlight who is at heightened risk for TD and current knowledge of post-TD sequelae, including irritable bowel syndrome, reactive arthritis, and, rarely, Guillain-Barré syndrome. This session will also discuss pros and cons of treating TD, in light of recent trends in global antibiotic resistance and growing concerns over travelers’ potential to acquire antibiotic-resistant flora, which persist long-term in their intestinal microbiome.
In this activity, Dr. Tan will speak on the scope of antibiotic resistance today and its widespread implications on society. With the help of case studies, she will discuss the how resistance develops and what steps can be taken to halt its spread in the community.
In this activity, Dr. Gupta will discuss how to effectively handle acute respiratory infections without over-prescribing antibiotics. She will also discuss best practices to help combat the rise of antibiotic resistance in the community.